Gunwant Guron is an Oncology physician affiliated with Saint Michael's Medical Center. OpenAlex indexes 117 publications with 349 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
268 Dr Martin Luther King Jr Blvd
Newark, NJ 071022011
Telephone
973-877-5434Registry record last updated 24 Jan 2008.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
- Janssen Biotech, Inc.Program year202513 payments
- GENZYME CORPORATIONProgram year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.5%Aromatase Inhibitor32.4%Anastrozole89%Letrozole12%Part D<11 patientsKinase inhibitor9.1%Imatinib Mesylate36%Jakafi34%Imbruvica30%Part D<11 patients+ 2 more classes in this area
Blood & clotting
35.1%Factor Xa inhibitor20.3%Eliquis79%Xarelto21%Part D<11 patientsVitamin K antagonist12.4%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Nervous system
8.9%Phenothiazine3.5%Prochlorperazine Maleate100%Part D≥11 patientsOpioid Agonist2.9%Oxycodone-Acetaminophen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020
Journal of Blood Medicine
2024 - BRAF Inhibitors in BRAF-Mutated Colorectal Cancer: A Systematic Review
Journal of Clinical Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Hamid Shaaban, MD
Saint Michael's Medical Center
Jack Boghossian, MD
Saint Michael's Medical Center
Sharath Bellary, MD
Saint Michael's Medical Center
Sudipa Chowdhury, DO
Saint Michael's Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”